SMTL ID : 6p8y.2 (1 other biounit)

Crystal structure of human KRAS G12C covalently bound to an acryloylazetidine acetamide inhibitor.

Coordinates

PDB Format

Method

X-RAY DIFFRACTION 2.31 Å

Oligo State

monomer

Ligands

1 x MG: MAGNESIUM ION(Non-covalent)

MG.1: 2 residues within 4Å: Chain A: S.31 Ligands: GDP.2 5 PLIP interactions: 1 interactions with chain A, 4 Ligand-Water interactions Metal complexes: A:S.31, H2O.1, H2O.1, H2O.1, H2O.1

1 x GDP: GUANOSINE-5'-DIPHOSPHATE(Non-covalent)

GDP.2: 18 residues within 4Å: Chain A: A.25, G.27, V.28, G.29, K.30, S.31, A.32, F.42, D.44, N.130, K.131, D.133, L.134, S.159, A.160, K.161 Ligands: MG.1, O5Y.3 17 PLIP interactions: 17 interactions with chain A Hydrogen bonds: A:G.27, A:V.28, A:G.29, A:K.30, A:S.31, A:A.32, A:D.44, A:N.130, A:K.131, A:K.131, A:A.160, A:K.161 Water bridges: A:S.31 Salt bridges: A:K.30, A:D.133 pi-Stacking: A:F.42, A:F.42

1 x O5Y: 2-[5-bromo-3-(5-methoxy-3,4-dihydroisoquinoline-2(1H)-carbonyl)-1H-indol-1-yl]-N-(1-propanoylazetidin-3-yl)acetamide(Covalent)

O5Y.3: 13 residues within 4Å: Chain A: V.23, G.24, C.26, K.30, P.48, A.73, M.86, D.106, H.109, Y.110, Q.113, I.114 Ligands: GDP.2 8 PLIP interactions: 8 interactions with chain A Hydrophobic interactions: A:V.23, A:H.109, A:Q.113 Hydrogen bonds: A:K.30, A:A.73, A:Y.110 pi-Stacking: A:Y.110, A:Y.110

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Shin, Y. et al., Discovery ofN-(1-Acryloylazetidin-3-yl)-2-(1H-indol-1-yl)acetamides as Covalent Inhibitors of KRASG12C. Acs Med.Chem.Lett. (2019)

Release Date

2019-08-28

Peptides

GTPase KRas: A

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
B

GTPase KRas

Related Entries With Identical Sequence